T2 Biosystems (NASDAQ:TTOO) Now Covered by StockNews.com

Equities research analysts at StockNews.com assumed coverage on shares of T2 Biosystems (NASDAQ:TTOO) in a research note issued on Friday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

T2 Biosystems Price Performance

T2 Biosystems stock opened at $0.12 on Friday. T2 Biosystems has a 12-month low of $0.06 and a 12-month high of $6.80. The firm’s fifty day moving average price is $0.13 and its 200 day moving average price is $0.53.

About T2 Biosystems

T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.